Nutrition labels have the best of intentions—to keep us healthy—but they sure don’t have the clearest of formats. Four in 10 North Americans admit to no better than a “partial” understanding of them, ...

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly ...

U.S. Department of Health & Human Services Secretary Tommy G. Thompson announced that food labels will be required to list the amount of unhealthy trans fatty acids, or trans fat, to give consumers ...

Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function Wegovy® (semaglutide 2.4 mg) is the first obesity ...